A pharmacy receives the following prescription: Auvi-Q 0.3 mg/0.3 mL Sig: 0.3 mg PO p.r.n. for severe allergic reaction Disp: 2 pack. The prescriber should be contacted to clarify the:

Rationale

The prescriber should be contacted to clarify the route of administration.

The prescription specifies Auvi-Q 0.3 mg/0.3 mL with a sig of "0.3 mg PO p.r.n.," which indicates an oral route. However, Auvi-Q is designed for subcutaneous administration. Thus, clarification is necessary to ensure the patient receives the medication correctly and safely.

A (quantity to dispense) YOUR ANSWER

The quantity to dispense is clearly stated in the prescription as "Disp: 2 pack," leaving no ambiguity regarding how much medication is to be provided to the patient. Therefore, there is no need for clarification on this aspect.

B (medication indication) YOUR ANSWER

While it is important to understand the indication for the medication, the prescription already mentions its use for "severe allergic reaction." This indication is clear and does not require further clarification from the prescriber.

C (medication strength) YOUR ANSWER

The strength of the medication is also explicitly provided in the prescription as "Auvi-Q 0.3 mg/0.3 mL." Since the strength is clearly defined, there is no reason to contact the prescriber for clarification on this matter.

D (route of administration) CORRECT

The prescription states "PO" (by mouth), but Auvi-Q is intended for subcutaneous use. This discrepancy indicates a potential error that must be clarified with the prescriber to ensure the patient receives the medication appropriately and safely.

Conclusion

In this case, the route of administration stands out as the critical aspect requiring clarification, given the mismatch between the prescribed oral route and the intended subcutaneous delivery of Auvi-Q. Ensuring accurate administration is essential for the efficacy and safety of the treatment for severe allergic reactions.

A pharmacy receives the following prescription: Auvi-Q 0.3 mg/0.3 mL Sig: 0.3 mg PO p.r.n. for severe allergic reaction Disp: 2 pack. The prescriber should be contacted to clarify the:

The prescriber should be contacted to clarify the route of administration.

Related Questions

Related Quizzes

How familiar were you with this question?

Report an Issue

Rate this Practice Test